SMTL ID : 6rfi.1 (1 other biounit)

IRAK4 IN COMPLEX WITH inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: F.27, H.28, S.29 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.29 Salt bridges: A:H.28

1 x K1H: methyl 4-[4-[(6-cyanoquinazolin-4-yl)amino]cyclohexyl]piperazine-1-carboxylate(Non-covalent)

K1H.2: 15 residues within 4Å: Chain A: M.54, G.55, E.56, V.62, A.73, K.75, Y.124, V.125, Y.126, M.127, S.131, D.134, L.139, L.180, S.190 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.62, A:V.62, A:A.73, A:Y.124, A:L.180 Hydrogen bonds: A:K.75, A:M.127 Water bridges: A:D.191 Salt bridges: A:E.56, A:D.134

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Degorce, S.L. et al., Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88L265PMutant Diffuse Large B Cell Lymphoma. J.Med.Chem. (2019)

Release Date

2019-10-30

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence